Clinical Trial Update: Comparison of Rapid Aflibercept and Brolucizumab T&E in wAMD [NA]

View source ↗

Summary

This clinical trial compares rapid aflibercept versus brolucizumab with a treat-and-extend approach in wet age-related macular degeneration and is currently act…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wet Age-related Macular Degeneration

Drugs mentioned

• BEOVU (BROLUCIZUMAB)
• EYLEA (Aflibercept)

Snippet

Sponsor: Berner Augenklinik | Conditions: Wet Age-related Macular Degeneration | NA | Status: ACTIVE_NOT_RECRUITING